Ross Camidge, MD, PhD

How An Interest in Translational Research and Drug Development Helps Evolve Regulatory Practices: With D. Ross Camidge, MD, PhD; and Gideon Blumenthal, MD

November 26th 2025

Drs Camidge and Blumenthal discussed Dr Blumenthal's experience serving on both sides of the oncology regulatory divide.

How a Career Dedicated to Patient Connections and Research Advances Has Improved Lung Cancer Care: With D. Ross Camidge, MD, PhD; and Mark Socinski, MD

November 12th 2025

Drs Camidge and Socinski discussed the highlights of Dr Socinski's career trajectory and the personal influences that helped him arrive where he is today.

Dr Camidge on the Efficacy and Safety of Neladalkib in ALK+ Solid Tumors

November 12th 2025

D. Ross Camidge, MD, PhD, discusses safety and efficacy data seen with neladalkib in TKI-naive and -pretreated patients with ALK-positive solid tumors.

Pivotal ARROS-1 Efficacy and Safety Data: Zidesamtinib in TKI Pretreated Patients With Advanced/Metastatic ROS1+ NSCLC

October 9th 2025

Ross Camidge, MD, PhD, discusses a pivotal phase 2/3 clinical trial (ARROS-1) evaluating the efficacy and safety of zidesamtinib in patients with advanced or metastatic ROS1-positive non–small cell lung cancer (NSCLC) who have previously received tyrosine kinase inhibitor (TKI) therapy.

How a Career of Hearing and Amplifying Patient Voices Has Reached the Pinnacle of Patient Advocacy: With D. Ross Camidge, MD, PhD; and Ken Culver, MD

September 10th 2025

Drs Camidge and Culver discuss the highlights of Dr Culver's career, shaped by clinical practice, research, leadership, and patient advocacy.

How Health Economics Leverages Clinical Research to Advance Patient Care: With D. Ross Camidge, MD, PhD; and Adam Lee

August 20th 2025

Camidge and Lee discussed Lee's professional journey and personal insights gained from years of working at the intersection of clinical research and patient care.

How Passion for Healing and Health Care Equity Expands Access to Innovative Therapies: With D. Ross Camidge, MD, PhD; and Brandon Blue, MD

July 30th 2025

Drs Camidge and Blue discussed Dr Blue’s journey into practicing medicine, and speciaffly how he settled on treating malignant hematologic conditions.

How Enthusiasm for Science and Global Change Culminates in Wide-Reaching Opportunities to Improve Cancer Care: D. Ross Camidge, MD, PhD; and Catharine Young, PhD

July 9th 2025

Camidge and Young discuss Young's career, which combined her passions for science and global engagement and led her to a Cancer Moonshot leadership role.

How Firsthand Breast Cancer Experience Shaped a Surgeon's Mission to Educate Colleagues and Empower Patients: With D. Ross Camidge, MD, PhD; and Liz O'Riordan, FRCS, PhD

June 18th 2025

D. Ross Camidge, MD, PhD sat down with Liz O'Riordan, FRCS, PhD, who describes herself as a breast surgeon who has had breast cancer.

How Unexpected Opportunities Shaped an Oncology Career Beyond the Clinic: With D. Ross Camidge, MD, PhD; and Lauren Meehan Machos, MPH

May 21st 2025

Camidge and Machos discussed Machos' early career transition from pre-med to sales, to her role in building strategic partnerships with key opinion leaders in oncology.

Advancing Brain Metastases Research and Mentorship in Breast Oncology: With D. Ross Camidge, MD, PhD; Nancy U. Lin, MD

April 30th 2025

Drs Camidge and Lin discussed Dr Lin's work with brain metastases and her role in developing targeted therapies for breast cancer.

How Medical Physicists Contribute to Optimized Oncologic Outcomes: With D. Ross Camidge, MD, PhD; and Alexandra Rink, PhD

March 19th 2025

Drs Camidge and Rink discuss Dr Rink's career in medical physics and the importance of multidisciplinary collaboration to deliver optimal patient care.

Vulnerable Conversations Contribute to Patient Advocacy Efforts to Propel Lung Cancer Research: With D. Ross Camidge, MD, PhD; and Tillman Nechtman, PhD

March 5th 2025

Drs Camidge and Nechtman discuss Dr Nechtman's experience supporting and caring for his wife Laura during her lung cancer diagnosis and treatment.

Dr Camidge on Best Practices for Biomarker Testing in NSCLC

February 24th 2025

D. Ross Camidge, MD, PhD, discusses the benefits of biomarker testing and the potential value of longitudinal testing in non–small cell lung cancer.

How Complementary Roles in Clinic and Industry Illuminate Avenues for Patient-Centered Cancer Care: With D. Ross Camidge, MD, PhD; and Geoff Oxnard, MD

February 19th 2025

Drs. Camidge and Oxnard discuss novel EGFR inhibitors, the role of precision medicine in early cancer detection, and balancing clinical and industry roles.

How Behavioral Science Informs Empathetic and Effective Lung Cancer Prevention Strategies: With D. Ross Camidge, MD, PhD; and Jamie L. Studts, PhD

February 12th 2025

Drs Camidge and Studts discuss Dr Studts' career in behavioral science and the importance of integrating lung cancer screening into primary care.

How Academia and Industry Intersect to Improve Oncology Research and Patient Care: With D. Ross Camidge, MD, PhD; and Tim Eisen, MB BChir, PhD

February 5th 2025

Drs Camidge and Eisen discuss Dr Eisen's dual career in academia and industry, the importance of aligning academic and clinical strengths, and how industry experience can enhance drug development.

How Generalists Are Uniquely Positioned to Administer and Advance Oncology Care: With D. Ross Camidge, MD, PhD; and Rahul Gosain, MD, MBA

January 29th 2025

A Nuanced Understanding of Cellular Biology Advances Neuro-Oncology Practice: With D. Ross Camidge, MD, PhD; and Adrienne A. Boire, MD, PhD

January 22nd 2025

Drs Camidge and Boire discuss Dr Boire's path to becoming a physician-scientist and how cellular biology research can improve outcomes for patients with cancer.

Designing Trials and Fueling Collaboration in Oncology: With D. Ross Camidge, MD, PhD; and Mary Redman, PhD

December 18th 2024

Drs Camidge and Redman discuss Dr Redman's role as a biostatistician at Fred Hutch, outlining her work in designing clinical trials.